Search results for "IVIg"

showing 8 items of 18 documents

IqYmune® is an effective maintenance treatment for multifocal motor neuropathy: A randomised, double‐blind, multi‐center cross‐over non‐inferiority s…

2018

Intravenous immunoglobulin (IVIg) is the gold-standard for maintenance treatment of multifocal motor neuropathy (MMN). This phase III, randomised, double-blind, multi-centre, active-control, crossover study, aimed to evaluate the non-inferiority of IqYmune® relative to Kiovig®, primarily based on efficacy criteria. Twenty-two adult MMN patients, treated with any brand of IVIg (except Kiovig® or IqYmune®) at a stable maintenance dose within the range of 1 to 2 g/kg every 4 to 8 weeks, were randomised to receive either Kiovig® followed by IqYmune®, or IqYmune® followed by Kiovig®. Each product was administered for 24 weeks. The primary endpoint was the difference between IqYmune® and Kiovig® …

Research ReportIVIgAdultMalemedicine.medical_specialtymultifocal motor neuropathyEquivalence Trials as Topiclaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled trialDouble-Blind MethodlawInternal medicineOutcome Assessment Health CaremedicineClinical endpointHumansImmunologic FactorsMotor Neuron DiseaseAgedCross-Over StudiesMaintenance dosebusiness.industryGeneral NeuroscienceImmunoglobulins IntravenousResearch Reportsclinical trialMiddle AgedHaemolysismedicine.diseaseCrossover studyConfidence intervalTolerability030220 oncology & carcinogenesisFemaleNeurology (clinical)businessimmunoglobulin030217 neurology & neurosurgeryMultifocal motor neuropathyJournal of the Peripheral Nervous System
researchProduct

Corallo per Santa Rosalia tra Sicilia e Spagna

2013

La presente ricerca punta a valorizzare le opere in corallo raffiguranti Santa Rosalia attraverso le principali emergenze artistiche nel periodo in cui fonte primaria di ispirazione per i maestri trapanesi e palermitani del corallo è il repertorio decorativo degli architetti del Senato palermitano Paolo e Giacomo Amato, talvolta con la collaborazione di Antonino Grano. La ricerca di Georgia Lo Cicero porta all’attenzione un ignorato trionfo in corallo con Santa Rosalia oggi custodito a Siviglia, insieme ad altri manufatti altamente rappresentativi della produzione artistica isolana della fine del XVII secolo, che costituiscono un’ulteriore testimonianza del filo rosso che legava Sicilia e S…

Settore L-ART/04 - Museologia E Critica Artistica E Del RestauroCoral Santa Rosalia decorative arts inventory Palermo Paolo Amato Giacomo Amato Antonino Grano triumph Seville Sicily Spaincorallo Santa Rosalia arti decorative repertorio Palermo Paolo Amato Giacomo Amato Antonino Grano trionfo Siviglia Sicilia Spagna.
researchProduct

"Largo al factotum!": genesi e fortuna del "Barbiere" di Rossini

2011

Il saggio ripercorre la genesi del "Barbiere di Siviglia" di Gioachino Rossini, soffermandosi sui problemi connessi alla determinazione dei ruoli vocali e della compagnia di canto, nonché alla genesi e alla prima rappresentazione dell'opera (Roma, Teatro Argentina, 20 febbraio 1816).

Settore L-ART/07 - Musicologia E Storia Della MusicaItalia Ottocento musica italiana melodramma Roma Teatro Argentina Giovanni Paisiello Gioachino Rossini Barbiere di Siviglia Pierre-Augustin Caron de Beaurmarchais Le barbier de Sèville
researchProduct

Avis de l'Anses relatif à l'actualisation de la méthode d'imputabilité des signalements d'effets indésirables de nutrivigilance

2019

A l’instar des autres systèmes de vigilance français et compte tenu de l’importance des conséquences en matière de santé et des décisions industrielles qui en découlent, l’analyse de la relation de causalité entre un produit visé par le dispositif national de nutrivigilance et l’effetindésirable déclaré doit être réalisée avec une méthode d’analyse appropriée et objective. Cette méthode dite « méthode d’imputabilité de nutrivigilance » estime le degré de causalité, d’un ou de plusieurs produits dans la survenue de l’effet indésirable déclaré, de manière standardisée, permettant d’éliminer les divergences d’opinion pouvant exister entre plusieurs observateurs. De telles méthodes sont couramm…

[SDV.AEN] Life Sciences [q-bio]/Food and NutritionComplément circonstancielImputabilitéFood supplementNutrivigilanceCausality assessmentEffet indésirableNutritional assessmentAdverse effectNutrition assessmentMESH: Nutrition Assessment[SDV.AEN]Life Sciences [q-bio]/Food and Nutrition
researchProduct

IVIG in APS pregnancy

2004

For more than two decades, the intravenous administration of high doses of IgG pooled from the plasma of healthy donors (immune globulin therapy, also known as ‘IVIG’) has benefited patients with a variety of autoimmune disorders. A potential therapeutic role of IVIG in the prevention of thrombosis and of miscarriages in antiphospholipid syndrome (APS) has been postulated. Multicenter randomized controlled trials attempted to define the role of IVIG in preventing pregnancy complications in APS indicate that simple anticoagulation could not be completely satisfactory, and certain patient subgroups might take advantage of IVIG therapy alone or in combination with heparin.

medicine.medical_specialtyAbortion Habitual030204 cardiovascular system & hematologyrecurrent fetal losslaw.invention03 medical and health sciences0302 clinical medicineRheumatologyRandomized controlled trialAntiphospholipid syndromelawPregnancyhemic and lymphatic diseasesInternal medicinemedicineHigh dosesHumans030203 arthritis & rheumatologyIVIGPregnancybiologybusiness.industryPregnancy Complications HematologicImmunoglobulins IntravenousThrombosisHeparinmedicine.diseaseAntiphospholipid SyndromeThrombosisPregnancy ComplicationsImmune Globulin TherapyImmunologybiology.proteinFemaleAntibodybusinessmedicine.drugAPS
researchProduct

Transfusion-related acute lung injury after intravenous immunoglobulin treatment in a lung transplant recipient

2012

Three weeks after single-lung transplantation for pulmonary fibrosis, a patient with high serum levels of de novo donor-specific antibodies received high-dose intravenous immunoglobulin (IVIG) infusion (scheduled dose: 2 g/kg on 2 days) to prevent antibody-mediated rejection. Within the first hours after completion of infusions, he experienced acute lung injury involving the transplanted lung. Given the clinical evolution and the absence of an alternative diagnosis, transfusion-related acute lung injury (TRALI) was diagnosed. The IVIG administered on each day was from the same batch. At day 110, because of an increase in the serum titers of donor-specific antibodies, IVIG therapy was reintr…

medicine.medical_specialtybiologybusiness.industrymedicine.medical_treatmentHematologyGeneral MedicineLung injurymedicine.diseaseSurgeryTransplantationhemic and lymphatic diseasesAnesthesiaPulmonary fibrosismedicinebiology.proteinLung transplantationLung transplant recipientAntibodybusinessIVIG TherapyTransfusion-related acute lung injuryVox Sanguinis
researchProduct

Prognostic Factors of Death in 151 Adults With Hemophagocytic Syndrome: Etiopathogenically Driven Analysis.

2018

Objective: To characterize the etiologies and clinical features at diagnosis of patients with hemophagocytic lymphohistiocytosis (HLH) and correlate these baseline features with survival using an etiopathogenically guided multivariable model. Patients and Methods: The Spanish Group of Autoimmune Diseases HLH Study Group, formed in 2013, is aimed at collecting adult patients with HLH diagnosed in internal medicine departments between January 3, 2013, and October 28, 2017. Results: The cohort consisted of 151 patients (91 men; mean age, 51.4 years). After a mean follow-up of 17 months (range, 1-142 months), 80 patients died. Time-to-event analyses for death identified a worse survival curve f…

medicine.medical_specialtymedicine.medical_treatmentHLH hemophagocytic lymphohistiocytosislaw.invention03 medical and health sciences0302 clinical medicinelawInternal medicineGC glucocorticoidEpidemiologymedicine030212 general & internal medicineSurvival analysislcsh:R5-920Hemophagocytic lymphohistiocytosisID immunosuppressive drugbusiness.industryMortality ratemedicine.diseaseICU intensive care unitIntensive care unitIVIG intravenous immunoglobulinImmunosuppressive drug030220 oncology & carcinogenesisCohortEtiologylcsh:Medicine (General)businessNK natural killerMayo Clinic proceedings. Innovations, qualityoutcomes
researchProduct

Drug Induced Liver Injury (DILI) due to variability in monacolin K content in Red Yeast Rice (RYR): An expert opinion

2020

Abstract Introduction Red yeast rice (RYR) is an effective cholesterol-lowering nutraceutical reversibly inhibiting 3-hydroxy-3-methyl-glutaryl-CoA (HMG-CoA) reductase. As liver damage is a possible (albeit rare) side effect of HMG-CoA inhibitors, it make sense to focus on the tolerability of the liver to RYR extracts. The aim of this paper is to offer an expert opinion on the risk of liver damage by the use of RYR extract. Methods A review of the available literature has been carried out and critically reviewed by the authors. Results According to a large meta-analysis of 53 randomized clinical trials comprising 112 treatment arms, which included 8535 subjects with 4437 in the RYR arm and …

nutrivigilancesafetyDrugSide effectmedia_common.quotation_subjectliver injury; monacolin K; nutrivigilance; red yeast rice; safety; tolerabilityPharmacologymonacolin K03 medical and health scienceschemistry.chemical_compound0302 clinical medicineNutraceuticalRed yeast rice Liver injury Monacolin K Safety Tolerability NutrivigilanceRed yeast riceMedicinered yeast rice030212 general & internal medicinetolerabilityLiver injury Monacolin K Nutrivigilance Red yeast rice Safety Tolerabilitymedia_commonLiver injurybusiness.industryRyanodine receptormusculoskeletal systemmedicine.disease030205 complementary & alternative medicineCitrininComplementary and alternative medicinechemistryTolerabilitycardiovascular systembusinesstissuesliver injury
researchProduct